← back to search

Josep M. del Campo

Hebron University ·
🔎 Find collaborators in Reproductive Medicine · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Reproductive Medicine · Oncology
Research interest
Research interests include Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Intraperitoneal and Appendiceal Malignancies, and Endometrial and Cervical Cancer Treatments.
h-index
18
citations
1,740
works
49
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
Clinical Cancer Research 2023cited by 22position: middledoi
MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum
Journal of Clinical Oncology 2020cited by 150position: middledoi
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial
Journal of Clinical Oncology 2019cited by 189position: firstdoi
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
The Lancet Oncology 2019cited by 86position: middledoi
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer
Gynecologic Oncology 2019cited by 68position: middledoi
Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study
Journal of Clinical Oncology 2016cited by 79position: middledoi
Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer
Journal of Clinical Oncology 2014cited by 328position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mansoor Raza Mirza · C4 Therapeutics (United States)2 papers (2019–2019)Philippe Follana · Université Claude Bernard Lyon 12 papers (2016–2019)Bradley J. Monk · University of Cincinnati Medical Center2 papers (2019–2019)Anne Lesoin · KU Leuven2 papers (2016–2019)Ignace Vergote · KU Leuven2 papers (2016–2019)Lucy Gilbert · McGill University Health Centre1 papers (2019–2019)Marta Gil-Martín · Universitat de Barcelona1 papers (2019–2019)B. Weber · Technische Universität Dresden1 papers (2016–2016)Alain Lortholary · Hôpital Tenon1 papers (2016–2016)Amit M. Oza · University Health Network1 papers (2019–2019)Éric Pujade-Lauraine · Hospital Universitario Ramón y Cajal1 papers (2016–2016)— · 1 papers (2019–2019)Bengt Tholander · Université Claude Bernard Lyon 11 papers (2016–2016)Susanne Malander · Lund University1 papers (2019–2019)Philipp Harter · University of Milano-Bicocca1 papers (2019–2019)Beatriz Pardo · Laboratory of Research in Fluid Dynamics and Combustion Technologies1 papers (2016–2016)Sandro Pignata · Iter1 papers (2019–2019)Gilles Freyer · Eau de Paris (France)1 papers (2016–2016)— · 1 papers (2019–2019)Anne Floquet · Institut Bergonié1 papers (2019–2019)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Reproductive Medicine · Oncology →